These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 16180226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.
    J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290
    [Abstract] [Full Text] [Related]

  • 5. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
    Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE.
    Breast Cancer Res Treat; 2006 Feb 01; 95(3):279-93. PubMed ID: 16163445
    [Abstract] [Full Text] [Related]

  • 6. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE.
    Ann Surg Oncol; 2008 Jul 01; 15(7):1996-2005. PubMed ID: 18415650
    [Abstract] [Full Text] [Related]

  • 7. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM.
    Eur J Surg Oncol; 2008 May 01; 34(5):508-13. PubMed ID: 17614245
    [Abstract] [Full Text] [Related]

  • 8. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):148-52. PubMed ID: 16387467
    [Abstract] [Full Text] [Related]

  • 9. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.
    Ann Surg Oncol; 2004 Nov 01; 11(11):1018-24. PubMed ID: 15525832
    [Abstract] [Full Text] [Related]

  • 10. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, Xu WP, Shao ZM, Shen ZZ, Wu J.
    Eur J Surg Oncol; 2009 Sep 01; 35(9):921-7. PubMed ID: 19233602
    [Abstract] [Full Text] [Related]

  • 11. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
    Albert US, Koller M, Kopp I, Lorenz W, Schulz KD, Wagner U.
    Breast Cancer Res Treat; 2006 Dec 01; 100(3):285-92. PubMed ID: 16710790
    [Abstract] [Full Text] [Related]

  • 12. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
    Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW.
    J Clin Oncol; 2005 Jul 01; 23(19):4312-21. PubMed ID: 15994144
    [Abstract] [Full Text] [Related]

  • 13. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Jul 01; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 14. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ.
    Cancer; 2003 Aug 15; 98(4):690-6. PubMed ID: 12910511
    [Abstract] [Full Text] [Related]

  • 15. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH, Fey JV, Raboy S, Thaler HT, Borgen PI, Temple LK, Van Zee KJ.
    Oncol Nurs Forum; 2002 May 15; 29(4):651-9. PubMed ID: 12011912
    [Abstract] [Full Text] [Related]

  • 16. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
    Leidenius M, Leivonen M, Vironen J, von Smitten K.
    J Surg Oncol; 2005 Oct 01; 92(1):23-31. PubMed ID: 16180231
    [Abstract] [Full Text] [Related]

  • 17. Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma.
    Bafford A, Gadd M, Gu X, Lipsitz S, Golshan M.
    Am J Surg; 2010 Sep 01; 200(3):374-7. PubMed ID: 20409517
    [Abstract] [Full Text] [Related]

  • 18. Medium-term follow-up data after sentinel node biopsy alone for breast cancer.
    Haid A, Knauer M, Köberle-Wührer R, Ammann K, Koller L, Eiter H, Lang A, Wenzl E.
    Eur J Surg Oncol; 2006 Dec 01; 32(10):1180-5. PubMed ID: 16750344
    [Abstract] [Full Text] [Related]

  • 19. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group.
    J Clin Oncol; 2007 Aug 20; 25(24):3657-63. PubMed ID: 17485711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.